Pulse nav.journalClub Debates ativos Tendências Explorar Perguntas Pesquisadores

Download the App

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

© Synapse Social LLC, 2026

Política de privacidade

Início Explorar nav.journalClub Tendências

⌘+K

DeepSynergy: predicting anti-cancer drug synergy with Deep Learning | Synapse

December 14, 2017Open Access

DeepSynergy: prevendo a sinergia de medicamentos anti-câncer com Aprendizado Profundo

Key Points

Key points are not available for this paper at this time.

Abstract

Dados suplementares estão disponíveis no Bioinformatics online.

Read Full Paperexternally

Like

Bookmark

Share

View Full Paper

Like

Bookmark

Share

View Full Paper

Cite This Study

Preuer et al. (Thu,) estudaram esta questão.

synapsesocial.com/papers/69d8af35d2f7327e70ae3f11 https://doi.org/https://doi.org/10.1093/bioinformatics/btx806

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Toxicophore exploration as a screening technology for drug design and discovery: techniques, scope and limitations2015 · 61 citations
2Bexarotene (LGD1069, Targretin), a Selective Retinoid X Receptor Agonist, Prevents and Reverses Gemcitabine Resistance in NSCLC Cells by Modulating Gene Amplification2007 · 70 citations
3Support-Vector Networks1995 · 33,056 citations
4Integration of virtual and high-throughput screening2002 · 942 citations
5Combination Therapy for Treatment of Infections with Gram-Negative Bacteria2012 · 829 citations